Nasdaq:US$15.21 (-0.78) | HKEX:HK$24.35 (+0.65) | AIM:£2.44 (-0.04)
新聞中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科學出版物 | 2010-11-30

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)